MINERVAX ApS: Financial statements 2013
CVR: 32673287
MINERVAX ApS (CVR 32673287) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 4,568,982 and a net result of DKK -2,146,519 compared with DKK -845,708 the year before. The profit margin was -47%. Equity amounted to DKK -719,299.
- Revenue
- 4,568,982 kr.
- Gross Profit
- -2,569,386 kr.
- Profit/Loss
- -2,146,519 kr.
- Equity
- -719,299 kr.
- Total Assets
- 7,133,315 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | 4.6 mio. | -2.6 mio. | -2.1 mio. | -719 t. | - |
| 2012 | - | -1.1 mio. | -846 t. | 1.4 mio. | - |
Find more companies like MINERVAX ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2013
As of December 4, 2013, Lars Thomas Joakim Areschoug has left the board of directors of MINERVAX ApS.
As of October 1, 2013, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of MINERVAX ApS.
As of October 1, 2013, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of MINERVAX ApS.
As of September 27, 2013, Ingelise Saunders has joined the board of directors of MINERVAX ApS.
As of September 27, 2013, Steen Søren Klysner has left the board of directors of MINERVAX ApS.
MINERVAX ApS has published its annual report for 2012. Gross profit came to DKK -1,060,392, and the net result was DKK -845,708.
As of April 5, 2013, Line Holten Reimer has joined the board of directors of MINERVAX ApS.
As of April 5, 2013, Ole Bitsch-Jensen has left the board of directors of MINERVAX ApS.
About MINERVAX ApS
MINERVAX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The company's owners include Novo Holdings A/S, SUNSTONE LIFE SCIENCE VENTURES FUND III K/S and Wellington Partners Life Sciences V GmbH & Co. KG. The company has 2 employees. In 2025, the company reported a net result of DKK -31,530,000 compared with DKK -29,126,000 the year before. Equity amounted to DKK 9,787,000.
